ARCHIVES

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

This article is from The Cancer Letter archive.

Vol. 07 No. 27 | July 3, 1981

Download PDF Visit The Full Archive

Related Articles

Grant Applications Pour Into NCI, NIH; Downward Trend In Funding Due To Be Reversed In FY 1979

June 16, 1978

Commentary: NCI’s Budge Proposal ForFY2001 Offers A Blueprint for Research

November 26, 1999

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004

Celgene Begins Two Studies With Hoffmann-La Roche.

June 29, 2001

CMS Inserts Unprecedented Conditions Into Medicare Coverage of Lung Screening

November 14, 2014

Carlson Named NCCN Chief Executive

September 28, 2012